Boehringer declares war on wormsFebruary 18, 2020Following the success of its Heartworm 2020 initiative, which saw 58,800 previously unprotected dogs receive heartworm disease prevention, Boehringer Ingelheim has upped the ante for 2021.
Education Center - SponsoredRethinking Our Approach to Canine OA: Treating synovial inflammationby • Exubrion TherapeuticsIt’s time to reframe arthritis not just as a painful condition, but as a disease of rampant synovial inflammation. In adopting a proactive treatment strategy that is aimed at modulating the inflammatory process, veterinarians can now provide more effective, long-term care.
